Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
Köser CU, Heyckendorf J, Andres S, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. Köser CU, et al. Among authors: schleusener v. Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00616-18. doi: 10.1128/AAC.00616-18. Print 2018 Aug. Antimicrob Agents Chemother. 2018. PMID: 30054377 Free PMC article. No abstract available.
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Heyckendorf J, Andres S, Köser CU, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. Heyckendorf J, et al. Among authors: schleusener v. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01550-17. doi: 10.1128/AAC.01550-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133554 Free PMC article.
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Lange C, et al. Among authors: schleusener v. J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. Online ahead of print. J Intern Med. 2018. PMID: 29806961 Free article.
Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.
Ajileye A, Alvarez N, Merker M, Walker TM, Akter S, Brown K, Moradigaravand D, Schön T, Andres S, Schleusener V, Omar SV, Coll F, Huang H, Diel R, Ismail N, Parkhill J, de Jong BC, Peto TE, Crook DW, Niemann S, Robledo J, Smith EG, Peacock SJ, Köser CU. Ajileye A, et al. Among authors: schleusener v. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02169-16. doi: 10.1128/AAC.02169-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28137812 Free PMC article.
Procalcitonin Impairs Endothelial Cell Function and Viability.
Wagner NM, Van Aken C, Butschkau A, Bierhansl L, Kellner P, Schleusener V, Seggewiss J, Vollmar B, Nöldge-Schomburg G, Roesner JP. Wagner NM, et al. Among authors: schleusener v. Anesth Analg. 2017 Mar;124(3):836-845. doi: 10.1213/ANE.0000000000001574. Anesth Analg. 2017. PMID: 27655274